Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Heart Rate Increase: Both adults and pediatric patients experienced mean increases in resting heart rate of 1 to 4 beats per minute (bpm) in semaglutide patients compared to placebo in clinical trials
It fights constipation, which affects 20-30% of people on these medications
Based on Phase 3 trial data, Retatrutide appears to produce greater average weight loss than semaglutide (the active ingredient in Wegovy and Ozempic)
Wegovy is approved for chronic weight management in obesity or overweight with comorbidities, and as of March 2024, for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight
US$ 22.85
US$ 21.07
US$ 24.52
US$ 25.43
US$ 20.07
